Choose your region:

Search
Close this search box.

CD autoplus (+ autofill)

Teledyne Hanson

CD autoplus (+ autofill)

Precision autosampling system with all-inert syringes, valves, tubing, and fluidics, designed for plug-and-play integration with CD14.

CD autoplus (+ autofill)

With 6 syringes (10 mL capacity) and a volume accuracy of ± 1% (0.1 mL), the CD AutoPlus easily accommodates sampling intervals under 5 minutes.

CD AUTOPLUS Dissoscan and Maximizer

The CD AutoPlus comes in two configurations, DissoScan™ and Maximizer™. Use the DissoScan with optional return-to-vessel (RTV) probes to recirculate rinse volumes, or the Maximizer™ for automated addition of dilutions or stabilizers, and its included media-replacement kit with low- evaporation vessel covers, 6 fixed probes (PEEK), and a 6-channel tubing harness.
The CD AutoPlus (38 cm W x 66 cm D) when combined with the CD14 dissolution tester provides the smallest 14-vessel footprint in its class.

CD AutoPlus Features

  • Handles surfactants and buffered media
  • Sample timing options: At Point or Midpoint
  • Seamless integration with space-saving AutoFill™ fraction collector stacked on top
  • Convenient auto-start feature
  • Programmable end-of-test wash routine automatically prepares system for next test
  • Print to serial and network printers
  • 21 CFR Part 11 security compliant with event logs, error logs, and full audit trail
  • USP / US FDA / ASTM / EP / JP / CE / CSA / RoHS compliant

AutoFill Features

  • Precision fraction collector fully compatible with all AutoPlus™ autosampler models
  • Wash port with end-of-test wash routine
  • Sample retrieval return to vessel accessory
  • CE / CSA / RoHS compliant
  • Choice of easy install collection racks with rack detection sensors
  • Compatible with 16 x 100 mm test tubes with evaporation caps, and 12 x 32 mm vials with  pre-cut septa

Related instruments

CD14 Comparative Dissolution

The CD14 dissolution tester runs two methods simultaneously or independently. Ideal for bioequivalence studies of generic vs. innovator drug formulations.